Saint Paul, MN, United States of America

Brendan J Young-Dixon

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Brendan J Young-Dixon: Innovator in Electrical Stimulation Technology

Introduction

Brendan J Young-Dixon is a notable inventor based in Saint Paul, MN (US), recognized for his contributions to the field of electrical stimulation technology. With a total of four patents to his name, he has made significant advancements that enhance medical devices and therapies.

Latest Patents

Brendan's latest patents include "Segmented lead independent electrode control for sensing or adaptive stimulation." This innovative system features a lead with multiple electrodes at different levels, allowing for symmetrical electrical stimulation and response sensing. Another significant patent is "Shape control for electrical stimulation therapy," which describes devices and techniques for adjusting therapy parameters while maintaining a specific ratio between multiple electrodes. This advancement ensures effective delivery of electrical stimulation therapy.

Career Highlights

Brendan is currently employed at Medtronic, Inc., a leading company in medical technology. His work focuses on developing advanced systems that improve patient outcomes through innovative electrical stimulation techniques. His expertise in this area has positioned him as a key contributor to the company's research and development efforts.

Collaborations

Brendan collaborates with talented professionals such as Lance Beall and Alicia Weller Thompson, who contribute to the innovative projects at Medtronic, Inc. Their teamwork fosters an environment of creativity and technical excellence.

Conclusion

Brendan J Young-Dixon's work in electrical stimulation technology exemplifies the impact of innovation in the medical field. His patents and contributions continue to shape the future of patient care through advanced therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…